The journal is licensed under a Attribution 4.0 International (CC BY 4.0).
All articles published in the Georgian Medical Journal (GMJ) are licensed under the
Creative Commons Attribution 4.0 International License (CC BY 4.0).
This license permits unrestricted use, distribution, and reproduction in any medium or format, including for commercial purposes, provided that the original author(s) and the source are properly credited.
Share — copy and redistribute the material in any medium or format for any purpose, including commercially.
Adapt — remix, transform, and build upon the material for any purpose, including commercially.
These freedoms cannot be revoked, provided that the license terms are followed.
Attribution — You must give appropriate credit to the author(s), provide a link to the license, and indicate if changes were made. This may be done in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Authors retain copyright of their work and grant the Georgian Medical Journal the right of first publication under the Creative Commons Attribution 4.0 International License (CC BY 4.0).
A new scientific commentary published in the Georgian Medical Journal examines the ethical and legal foundations for including critically ill patients in clinical research. The article is based on international standards and the Georgian regulatory context and is available in English with a DOI.
An overview of the evolution of ISO 15189—from a technical laboratory standard to a foundation of patient safety and health system trust—highlighting the roles of international organisations, WHO, and modern accreditation frameworks.
